-
1Academic Journal
Authors: S. V. Popov, R. G. Huseynov, E. V. Pomeshkin, O. N. Scriabin, K. V. Sivak, V. V. Perepelitsa, T. A. Lelyavina, E. A. Malyshev, С. В. Попов, Р. Г. Гусейнов, Е. В. Помешкин, О. Н. Скрябин, К. В. Сивак, В. В. Перепелица, Т. А. Лелявина, Е. А. Малышев
Source: Urology Herald; Том 12, № 3 (2024); 70-78 ; Вестник урологии; Том 12, № 3 (2024); 70-78 ; 2308-6424 ; 10.21886/2308-6424-2024-12-3
Subject Terms: мочевой пузырь, transurethral resection of the bladder, laser resection, recurrence, bladder, трансуретральная резекция мочевого пузыря, лазерная резекция, рецидив
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/884/564; Гусниев М.А., Печникова В.В., Гущин М.Ю., Гусниев С.А., Гиоева З.В., Пшихачев А.М., Михалева Л.М. Анализ факторов риска рецидива немышечно-инвазивного рака мочевого пузыря после его комбинированного лечения. Медицинский вестник Северного Кавказа. 2022;17(3):264-268. DOI:10.14300/mnnc.2022.17064; Shore ND, Palou Redorta J, Robert G, Hutson TE, Cesari R, Hariharan S, Rodríguez Faba Ó, Briganti A, Steinberg GD. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. Urol Oncol. 2021;39(10):642-663. DOI:10.1016/j.urolonc.2021.05.015; Иванов С.А., Заборский И.Н., Чайков В.С. Лечение немышечно-инвазивного рака мочевого пузыря высокого риска. Вестник урологии. 2017;5(2):42-49. DOI:10.21886/2308-6424-2017-5-2-42-49; Al Hussein Al Awamlh B, Chang SS. Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer. Curr Oncol Rep. 2023;25(2):83-91. DOI:10.1007/s11912-022-01350-9; Бабаевская Д.И., Базаркин А.К., Тараткин М.С., Еникеев Д.В. Новейшие достижения в трансуретральной резекции стенки мочевого пузыря с опухолью. Вестник урологии. 2022;10(1):96-103. DOI:10.21886/2308-6424-2022-10-1-96-103; Ивахно К.Ю., Важенин А.В., Карнаух П.А., Мисюкевич Н.Д. Мировой опыт применение тулиевого лазера в лечении мышечно-неинвазивного рака мочевого пузыря. Вестник Совета молодых учёных и специалистов Челябинской области. 2018;2(1):111-112. eLIBRARY ID: 35010553; EDN: XOXQBV; Li C, Gao L, Zhang J, Yang X, Liu C. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Lasers Med Sci. 2020;35(5):1025-1034. DOI:10.1007/s10103-020-02972-w; Chen J, Zhao Y, Wang S, Jin X, Sun P, Zhang L, Wang M. Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: A prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med. 2016;48(9):859-865. DOI:10.1002/lsm.22565; Xu Y, Guan W, Chen W, Xie C, Ouyang Y, Wu Y, Liu C. Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study. Lasers Surg Med. 2015;47(4):306-311. DOI:10.1002/lsm.22342; Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, Fan ZL, Han P, Huang YR, Huang X, Li M, Li XD, Li YN, Li XH, Liang CZ, Liu JM, Ma HS, Qi J, Shi JQ, Wang J, Wang DL, Wang ZP, Wang YY, Wang YB, Wei Q, Xia HB, Xing JC, Yan SY, Zhang XP, Zheng GY, Xing NZ, He DL, Wang XH; Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange, Promotive Association for Medical, Health Care (CPAM-UHPA). Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. 2022;9(1):44. DOI:10.1186/s40779-022-00406-y; Musat MG, Kwon CS, Masters E, Sikirica S, Pijush DB, Forsythe A. Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR). Clinicoecon Outcomes Res. 2022;14:35-48. DOI:10.2147/CEOR.S341896; Liem EIML, Freund JE, Savci-Heijink CD, de la Rosette JJMCH, Kamphuis GM, Baard J, Liao JC, van Leeuwen TG, de Reijke TM, de Bruin DM. Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading. Eur Urol Focus. 2020;6(1):81-87. DOI:10.1016/j.euf.2018.07.012; Poletajew S, Krajewski W, Gajewska D, Sondka-Migdalska J, Borowik M, Buraczyński P, Dzięgała M, Łykowski M, Przudzik M, Tukiendorf A, Woźniak R, Bar K, Jabłonowski Z, Roslan M, Słojewski M, Zdrojowy R, Radziszewski P, Dziobek K. Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour - a prospective multicentre observational study. Arch Med Sci. 2019;16(4):863-870. DOI:10.5114/aoms.2019.88430; Kamadjou C, Kuitche J, Wadeu A, Mbassi A, Angwafo F. Transurethral Resection of Bladder Tumours: Results and Outcomes. Open Journal of Urology. 2022;12:342-356. DOI:10.4236/oju.2022.126033; Lonati C, Esperto F, Scarpa RM, Papalia R, Gómez Rivas J, Alvarez-Maestro M, Afferi L, Fankhauser CD, Mattei A, Colombo R, Montorsi F, Briganti A, Krajewski W, Carando R, Laukhtina E, Teo JY, Zamboni S, Simeone C, Moschini M; European Association of Urology - Young Academic Urologists (EAU-YA U): Urothelial Carcinoma Working Group; European Association of Urology - European Society of Resident Urologists (EAU-ESRU). Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-up. Minerva Urol Nephrol. 2022;74(5):570-580. DOI:10.23736/S2724-6051.21.04436-0; Long G, Zhang Y, Sun G, Ouyang W, Liu Z, Li H. Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis. Lasers Med Sci. 2021;36(9):1807-1816. DOI:10.1007/s10103-021-03272-7; https://www.urovest.ru/jour/article/view/884
-
2Academic Journal
Authors: I. N. Zaborskii, K. N. Safiullin, O. B. Karyakin, S. A. Ivanov, V. S. Chaikov, I. O. Dementev, A. V. Sidorin, G. N. Grishin, A. N. Yurchenko, И. Н. Заборский, К. Н. Сафиуллин, О. Б. Карякин, С. А. Иванов, В. С. Чайков, И. О. Дементьев, А. В. Сидорин, Г. Н. Гришин, А. Н. Юрченко
Source: Research and Practical Medicine Journal; Том 7, № 2 (2020); 129-143 ; Research'n Practical Medicine Journal; Том 7, № 2 (2020); 129-143 ; 2410-1893 ; 10.17709/2409-2231-2020-7-2
Subject Terms: трансуретральная резекция мочевого пузыря, diagnosis, cystoscopy, photodynamic diagnosis, narrow-spectrum diagnosis, transurethral resection of the bladder, диагностика, цистоскопия, фотодинамическая диагностика, узкоспектровая диагностика
File Description: application/pdf
Relation: https://www.rpmj.ru/rpmj/article/view/546/365; Состояние онкологической помощи населению России в 2018 году под редакцией А.Д. Каприна, В.В. Старинского, Г.В. Петровой, 2019.; Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC Cancer Staging Manual, 8th ed. Springer International Publishing: New York; 2017. Available from: https://www.springer.com/gp/book/9783319406176; Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) — 2019 Update. Eur Urol. 2019 Nov; 76(5): 639–657. https://doi.org/10.1016/j.eururo.2019.08.016; Алексеев Б. Я., Андронов А. С., Атдуев В. А., Байков Н. А., Важенин А. В., Васильев О.Н. и др. Рак мочевого пузыря (классика и новации). Медфорум. Монография. Москва, 2017, 262 с.; Иванов С.А., Заборский И.Н., Чайков В.С. Лечение немышечно-инвазивного рака мочевого пузыря высокого риска. Вестник Урологии. 2017; 5(2): 42–49. https://doi.org/10.21886/2308–6424–2017–5-2–42–49; Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2017; 71(3): 447–461. https://doi.org/10.1016/j.eururo.2016.05.041; Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors-results of a prospective, randomized comparison to the standard approach. Urology. 2012 Apr; 79(4): 846–851. https://doi.org/10.1016/j.urology.2011.08.081; Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, et al. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10): 589–596. https://doi.org/10.1038/nrurol.2014.245; Malmström P‐U, Agrawal S, Bläckberg M, Boström PJ, Malavaud B, Zaak D, et al. Non-muscle-invasive bladder cancer: a vision for the future. Scand J Urol. 2017 Apr; 51(2): 87–94. https://doi.org/10.1080/21681805.2017.1283359; Isfoss BL. The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard. BJU Int. 2011 Dec; 108(11): 1703–1707. https://doi.org/10.1111/j.1464–410X.2011.10485.x; Лоран О.Б., Серегин А.В., Дадашев Э.О., Бабаев А.Б., Лощенов В.Б. Фотодинамическая диагностика отечественной флуоресцентной видеосистемой неинвазивного рака мочевого пузыря. Consilium Medicum. 2018; 20(7): 37–40. https://doi.org/10.26442/2075–1753_2018.7.37–40; Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013 Nov; 64(5): 846–854. https://doi.org/10.1016/j.eururo.2013.03.059; Kamat A, Cookson M, Witjes JA, Stenzl A, Grossman HB. TheImpact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer — A New Analysis. Bladder Cancer. 2016 Apr 27; 2(2): 273–278. https://doi.org/10.3233/BLC-160048; Daneshmand S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, Willard B, Taylor JM, et al. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. Urol Oncol. 2018; 36(8): 361.e1–361.e6. https://doi.org/10.1016/j.urolonc.2018.04.013; Gallagher KM, Gray K, Anderson CH, Lee H, Stewart S, Donat R, et al. “Real-life experience”: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC-a prospective controlled study. World J Urol. 2017 Dec; 35(12): 1871–1877. https:// doi.org/10.1007/s00345–017–2077–6; Bach T, Bastian PJ, Blana A, Kaminsky A, Keller S, Knoll T, et al. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III. World J Urol. 2017 May; 35(5): 737–744. https://doi.org/10.1007/s00345–016–1925–0; Pagliarulo V, Alba S, Gallone MF, Di Stasi S, Cormio L, Petitti T, et al. Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy. J Endourol. 2017; 31(4): 405–411. https://doi.org/10.1089/end.2016.0804; Drăgoescu PO, Tudorache Ş, Drocaş AI, Mitroi G, Pănuş A, Drăgoescu NAM, et al. Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis. Rom J Morphol Embryol. 2017; 58(4): 1279–1283.; Lykke MR, Nielsen TK, Ebbensgaard NA, Zieger K. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis. Scand J Urol. 2015 Jun; 49(3): 230–236. https://doi.org/10.3109/21681805.2015.1019562; Kata SG, Zreik A, Ahmad S, Chłosta P, Aboumarzouk O. Concurrent bladder cancer in patients undergoing photodynamic diagnostic ureterorenoscopy: how many lesions do we miss under white light cystoscopy? Cent European J Urol. 2016; 69(4): 334–340. https://doi.org/10.5173/ceju.2016.896; Kim SB, Yoon SG, Tae J, Kim JY, Shim JS, Kang SG, et al. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy. Investig Clin Urol. 2018; 59(2): 98–105. https://doi.org/10.4111/icu.2018.59.2.98; Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, et al. Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa 8 Study. Urology. 2017; 102: 138–142. https://doi.org/10.1016/j.urology.2016.11.032; Naito S, Algaba F, Babjuk M, Bryan RT, Sun Y H, Valiquette L, et al. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1 year Results. Eur Urol. 2016; 70(3): 506–515. https://doi.org/10.1016/j.eururo.2016.03.053; Xiong Y, Li J, Ma S, Ge J, Zhou L, Li D, et al. A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer. PLoS ONE. 2017; 12(2): e0170819. https://doi.org/10.1371/journal.pone.0170819; Bryan RT, Shah ZH, Collins SI, Wallace DMA. Narrow-bandimaging flexible cystoscopy: a new user’s experience. J Endourol. 2010 Aug; 24(8): 1339–1343. https://doi.org/10.1089/end.2009.0598; Kang W, Cui Z, Chen Q, Zhang D, Zhang H, Jin X. Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis. Oncotarget. 2017 Apr 4; 8(14): 23880. https://doi.org/10.18632/oncotarget.13054; Geavlete BF, Brînzea A, ChecheriŢă IA, Zurac SA, GeorgescuDA, Bastian AE, et al. Carcinoma in situ of the urinary bladder — from pathology to narrow band imaging. Rom J Morphol Embryol. 2015; 56(3): 1069–1076.; Lee JY, Cho KS, Kang DH, Jung HD, Kwon JK, Oh CK, et al. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5 aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer. 2015 Aug 1; 15: 566. https://doi.org/10.1186/s12885–015–1571–8; Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991 Nov 22; 254(5035): 1178–1181. https://doi.org/10.1126/science.1957169; Huang J, Ma X, Zhang L, Jia H, Wang F. Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis. Mol Clin Oncol. 2018 Apr; 8(4): 609–612. https://doi.org/10.3892/mco.2018.1566; Xiong YQ, Tan J, Liu Y M, Li Y Z, You F F, Zhang M Y, et al. Diagnostic accuracy of optical coherence tomography for bladder cancer: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2019 Sep; 27: 298–304. https://doi.org/10.1016/j.pdpdt.2019.06.006; Lerner SP, Goh A. Novel endoscopic diagnosis for bladder cancer. Cancer. 2015 Jan 15; 121(2): 169–178. https://doi.org/10.1002/cncr.28905; Chang TC, Liu J J, Hsiao ST, Pan Y, Mach KE, Leppert JT, et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol. 2013 May; 27(5): 598–603. https://doi.org/10.1089/end.2012.0549; Liem EI, Freund JE, Baard J, de Bruin DM, Laguna Pes MP, Savci-Heijink CD, et al. Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies. JMIR Res Protoc. 2018 Feb 7; 7(2): e34. https://doi.org/10.2196/resprot.8862; Rao AR, Hanchanale V, Javle P, Karim O, Motiwala H. Spectroscopic view of life and work of the Nobel Laureate Sir C.V. Raman. J Endourol. 2007 Jan; 21(1): 8–11. https://doi.org/10.1089/end.2006.9998; Schäfauer C, Ettori D, Rouprêt M, Phé V, Tualle J M, Tinet E, et al. Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. J Urol. 2013 Jul; 190(1): 271–277. https://doi.org/10.1016/j.juro.2013.01.100; Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol. 2003 Nov; 21(11): 1369–1377. https://doi.org/10.1038/nbt899; Jain M, Robinson BD, Scherr DS, Sterling J, Lee M–M, Wysock J, et al. Multiphoton microscopy in the evaluation of human bladder biopsies. Arch Pathol Lab Med. 2012 May; 136(5): 517–526. https://doi.org/10.5858/arpa.2011–0147-OA; Tewari AK, Shevchuk MM, Sterling J, Grover S, Herman M, Yadav R, et al. Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery. BJU Int. 2011 Nov; 108(9): 1421–1429. https://doi.org/10.1111/j.1464–410X.2011.10169.x; Rivera DR, Brown CM, Ouzounov DG, Pavlova I, Kobat D, Webb WW, et al. Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue. Proc Natl Acad Sci USA. 2011 Oct 25; 108(43): 17598–17603. https://doi.org/10.1073/pnas.1114746108; Seibel EJ, Brentnall TA, Dominitz JA. New endoscopic and cytologic tools for cancer surveillance in the digestive tract. Gastrointest Endosc Clin N Am. 2009 Apr; 19(2): 299–307. https://doi.org/10.1016/j.giec.2009.02.002; Seibel EJ, Brown CM, Dominitz JA, Kimmey MB. Scanning single fiber endoscopy: a new platform technology for integrated laser imaging, diagnosis, and future therapies. Gastrointest Endosc Clin N Am. 2008 Jul; 18(3): 467–478, viii. https://doi.org/10.1016/j.giec.2008.05.001; Yoon WJ, Park S, Reinhall PG, Seibel EJ. Development of an Automated Steering Mechanism for Bladder Urothelium Surveillance. J Med Device. 2009 Mar 1; 3(1): 11004. https://doi.org/10.1115/1.3054381; https://www.rpmj.ru/rpmj/article/view/546
-
3
-
4Academic Journal
Authors: F. R. Asfandiyarov, V. Yu. Startsev, A. Yu. Kolmakov, Ф. Р. Асфандияров, В. Ю. Старцев, А. Ю. Колмаков
Source: Urology Herald; Том 6, № 3 (2018); 5-11 ; Вестник урологии; Том 6, № 3 (2018); 5-11 ; 2308-6424 ; 10.21886/2308-6424-2018-6-3
Subject Terms: трансуретральная резекция мочевого пузыря, Schistosoma mansoni, urogenital schistosomiasis, cytological examination of urine sediment, cystoscopy, transurethral resection of the bladder, урогенитальный шистосомоз, цитологическое исследование осадка мочи, цистоскопия
File Description: application/pdf
Relation: https://www.urovest.ru/jour/article/view/213/181; International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum.1994;61:45-100.; World Health Organiza on. Fact sheet N.115: Schistosomiasis. Электронный ресурс. WHO. Электрон, текстовые дан. – Режим доступа: h p://www.who.int/mediacentre/factsheets/fs115/en/. Accessed October 2017; Брико Н.И., Покровский В.И. Глобализация и эпидемический процесс. Эпидемиология и инфекционные болезни. 2010;4:6.; Maestro MA, Gonzalez ER, Garcia PD et al. Bladder schistosomiasis: case report and bibliographic review. Arch. Esp. Urol. 2010;63(7):554-558. PMID: 20945592; Boissier J, Grech-Angelini S, Webster BL et al. Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. Lancet Infect. Dis. 2016;16(8):971-979. DOI:10.1016/S1473-3099(16)00175-4; Бронштейн А.М., Малышев Н.А., Жаров С.Н. Острый мочеполовой шистосомоз у туриста, посетившего Уганду и Кению: описание случая и обзор литературы. Эпидемиология и инфекционные болезни. 2012;5:47-50.; Катаханова Л.Л., Савин В.А., Исаева Я.В, Болотская Т.Г. Случай мочеполового шистосомоза у ребенка 10 лет. Вестник Сургута. 2013;1(15):59-61.; Шахулина Л.Р., Валшин Д. А., Хунафина Д.Х., Галиева А.Т. Мочеполовой шистосомоз, клинический случай. Инфекционные болезни. 2017;15(1):317.; Brito de PA, Kazura JW, Mahmoud AA. Host granulomatous response in Schistosomiasis mansoni An body and cellmediated damage of parasite eggs in vitro. J. Clin. Invest. 1984;74(5):1715–1723. DOI:10.1172/JCI111589; Savioli L, Renganathan E, Montresor A et al. Division of control of Tropical Diseases, Schistomiasis and Intes nal Parasites unit, World Health Organiza on. Control of schistosomiasis—a global picture. Parasitol. Today.1997;13:444–448; Alwan MH, Al-Shukri S, Lafi MO. Bilharzial Anuria. Bahrain Medical Bulle n. 1984;6(3):78-80.; Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int. 2004;93:216–220. PMID: 14690486; Bichler КH, Savatovsky I, Members of the Urinary Tract Infec on (UTI) Working Group of the Guidelines Offi ce of the European Associa on of Urology (EAU): Naber KG, Bischop MC, Bjerklund-Johansen TE, Bo o H, Cek M, Grabe M, Lobel B, Redorta JP, Tenke P. EAU Guidelines for the Management of Urogenital Schistosomiasis. Eur Urol. 2006. 49(6):9981003. DOI:10.1016/j.eururo.2006.02.022; Gen le JM. Schistosome related cancers: a possible role for genotoxins. Environ. Mutagen.1985;7:775–785. DOI:10.1002/em.2860070514; https://www.urovest.ru/jour/article/view/213
-
5Academic Journal
Authors: K. O. Tsedenova, M. I. Komarov, A. D. Panakhov, V. B. Matveev, D. A. Sergeev, A. A. Beshtoev, К. О. Цеденова, М. И. Комаров, А. Д. Панахов, В. Б. Матвеев, Д. А. Сергеев, А. А. Бештоев
Source: Cancer Urology; Том 14, № 4 (2018); 103-109 ; Онкоурология; Том 14, № 4 (2018); 103-109 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-4
Subject Terms: трансуретральная резекция мочевого пузыря, small-cell carcinoma of the bladder, neuroendocrine cancer, neurourothelial carcinoma of the bladder, radical cystectomy, neoadjuvant chemotherapy, transurethral resection of the bladder, мелкоклеточный рак мочевого пузыря, нейроэндокринный рак, неуротелиальный рак мочевого пузыря, радикальная цистэктомия, неоадъювантная химиотерапия
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/816/813; Ferlay J. GLOBOCAN 2012 v1.0: Esti-mated cancer incidence, mortality and prevalence worldwide in 2012. 2013. Available at: http://globocan.iarc.fr/Default.aspx.; Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. 250 с.; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67(1):7—30. DOI:10.3322/caac.21387. PMID: 28055103.; WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th edn. Lyon, France, 2016.; Kapur P., Lotan Y., King E. et al. Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers. Am J Clin Pathol 2011;135(6):822—30. DOI:10.1309/AJCP76KUVOTBKQRY. PMID: 21571954.; Ploeg M. Clinical epidemiology of nonurothelial bladder cancer: analyses of the Netherlands Cancer Registry. J Urol 2010;183:915.; Beltran A.L., Cheng L., Montironi R. et al. Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder. Virchows Arch 2014;465(2):199—205. DOI:10.1007/s00428-014-1601-y. PMID: 24878757.; Mukesh M., Cook N., Hollingdale A.E. et al. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int 2009;103(6):747— 52. DOI:10.1111/j.1464-410X.2008.08241.x. PMID: 19076139.; John Hopkins Department of Pathology. Available at: http://pathologyjhu.edu/bladdercancer.; Walther PJ. Adjuvant/neoadjuvant etoposide/cisplatin and cystectomy for management of invasive small cell carcinoma. J Urol 2002;167(4):285. [Abstract 1124].; Trias I., Algaba F., Condom E. et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol 2001;39(1): 85—90. DOI:10.1159/000052417. PMID: 11173944.; Grignon D.J. Neoplasms of the urinary bladder. In: Urologic surgical pathology. Eds.: D.G. Bostwick, J.N. Eble. St. Louis (MO): Mosby-Year Book, Inc, 1997. Pp. 216—305.; Blomjous C.E., Vos W., De Voogt H.J. et al. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 1989;64(6):1347—57. PMID: 2548704.; Helpap B. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer 2002;95(7):1415—20. DOI:10.1002/cncr.10840. PMID: 12237909.; Holmang S., Borghede G., Johansson S.L. Primary small cell carcinoma of the bladder: a report pf 25 cases. J Urol 1995;153(6):1820—2. PMID: 7752326.; Rogers C.G., Palapattu G.S., Shariat S.F. et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol 2006;175(6):2048—53. DOI:10.1016/S0022-5347(06)00317-X. PMID: 16697800.; Koay E.J., Teh B.S., Paulino A.C. Butler E.B. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 2012;83(1):64—70. DOI:10.1016/j.ijrobp.2011.05.039. PMID: 22019246.; Bryant C.M., Dang L.H., Stechmiller B.K. et al. Treatment of small cell carcinoma of the bladder with chemotherapy and radiation after transurethral resection of a bladder tumor. Am J Clin Oncol 2016;39(1):69—75. DOI:10.1097/COC.0000000000000027. PMID: 24517956.; Fischer-Valuck B.W., Rao Y.J., Henke L.E. et al. Treatment patterns and survival outcomes for patients with small cell carcinoma of the bladder. Eur Urol Focus 2017. DOI:10.1016/j.euf.2017.09.001. PMID: 28919521.; Schreiber D., Rineer J., Weiss J. et al. Characterization and outcomes of small cell carcinoma of the bladder using the Surveillance, epidemiology, and end results database. Am J Clin Oncol 2013;36(2):126— 31. DOI:10.1097/COC.0b013e3182438c71. PMID: 22391430.; Lohrisch C., Murray N., Pickles T., Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer 1999;86(11):2346—52. PMID: 10590377.; Bex A., Nieuwenhuijzen J.A., Kerst M. et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 2005;65(2):295—9. DOI:10.1016/j.urology.2004.09.049. PMID: 15708041.; Pasquier D., Barney B., Sundar S. et al. Small cell carcinoma of the urinary bladder: a retrospective, multicenter rare cancer network study of 107 patients. Int J Radiat Oncol Biol Phys 2015;92(4):904—10. DOI:10.1016/j.ijrobp.2015.03.019. PMID: 26104942.; Siefker-Radtke A.O., Kamat A.M., Grossman H.B. et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol DOI:10.1200/JC0.2008.19.0256. PMID: 19414678.; Lynch S.P., Shen Y., Kamat A. et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol201;64(2):307—13. DOI:10.1016/j.eururo.2012.04.020. PMID: 22564397.; https://oncourology.abvpress.ru/oncur/article/view/816
-
6Academic Journal
Authors: N. I. Sorokin, D. V. Enikeev, A. M. Dymov, D. G. Tsarichenko, D. A. Kislyakov, G. Yu. Gololobov, L. O. Severgina, L. M. Rapoport, Н. И. Сорокин, Д. В. Еникеев, А. М. Дымов, Д. Г. Цариченко, Д. А. Кисляков, Г. Ю. Гололобов, Л. О. Севергина, Л. М. Рапопорт
Source: Cancer Urology; Том 14, № 1 (2018); 144-151 ; Онкоурология; Том 14, № 1 (2018); 144-151 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-1
Subject Terms: «Уролаз», urothelial carcinoma, transurethral resection of bladder tumor, thulium laser, en bloc resection, “Urolaz”, уротелиальная карцинома, трансуретральная резекция мочевого пузыря, тулиевый лазер, резекция единым блоком
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/791/744; Antoni S., Ferlay J., Soerjomataram I. et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017;71(1):96–108. DOI: http://dx.doi.org/10.1016/j.eururo.2016.06.010. PMID: 27370177.; Каприн А.Д., Аполихин О.И., Сивков А.В. и др. Анализ уронефрологической заболеваемости и смертности в Российской Федерации за 2003–2013 гг. Экспериментальная и клиническая урология 2015;(2):4–13.; Jemal A., Bray F., Center M.M. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90. DOI: https://doi.org/10.3322/caac.20107. PMID: 21296855.; Ridge C.A., Pua B.B., Madoff D.C. Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol 2014;31(1):3–8. DOI: https://doi.org/10.1055/s-0033-1363837. PMID: 24596434.; Tyson M.D., Lee D., Clark P. New developments in the management of nonmuscle invasive bladder cancer. Curr Opin Oncol 2017;29(3):179–83. DOI:10.1097/cco.0000000000000362. PMID: 28282341.; EAU Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS). European Association of Urology. Guidelines 2017. Pp. 4–40.; Мартов А.Г., Ергаков Д.В., Байков Н.А. и др. Трансуретральное удаление опухолей мочевого пузыря единым блоком. Онкоурология 2015;(1):41–9. DOI:10.17650/1726-97762015-1-41-49.; Bryan R.T., Collins S.I., Daykin M.C. et al. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl 2010;92(6):519–24. DOI:10.1308/003588410x12664192076935. PMID: 20522307.; Kamat A.M., Bağcıoğlu M., Huri E. What is new in non-muscle-invasive bladder cancer in 2016. Turk J Urol 2017;43(1):9–13. DOI:10.5152/tud.2017.60376. PMID: 28270945.; Grimm M.O., Steinhoff C., Simon X. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003;170(2 Pt 1):433–7. DOI:10.1097/01.ju.0000070437.14275.e0. PMID: 12853793.; Staehler G., Schmiedt E., Hofstetter A. Destruction of bladder neoplasms by means of transurethral neodym-YAGlaser coagulation. Helv Chir Acta 1978;45(3):307–11. PMID: 568126.; Kawada T., Ebihara K., Suzuki T. et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 1997;157(6):2225–6. PMID: 9146621.; Kramer M.W., Rassweiler J.J., Klein J. et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 2015;33(12):1937–43. DOI:10.1007/s00345-015-1568-6. PMID: 25910478.; EAU Guidelines on lasers and technologies. European Association of Urology. Guidelines 2016. Pp. 6–55.; Babjuk M., Böhle A., Burger M. et al. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017;71(3):447–61. DOI:10.1016/j.eururo.2016.05.041. PMID: 27324428.; Wu Y.P., Lin T.T., Chen S.H. et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: a meta-analysis. Medicine (Baltimore) 2016;95(45):e5372. DOI:10.1097/MD.0000000000005372. PMID: 27828864.; https://oncourology.abvpress.ru/oncur/article/view/791
-
7Academic Journal
Authors: M. M. Ulyanin, G. Т. Basiashvili, R. Sh. Khasanov, I. G. Gataullin, M. V. Burmistrov, G. R. Khayrullina, M. Ю. Ульянин, Г. Т. Басиашвили, Р. Ш. Хасанов, И. Г. Гатауллин, М. В. Бурмистров, Г. Р. Хайруллина
Source: Cancer Urology; Том 11, № 4 (2015); 42-50 ; Онкоурология; Том 11, № 4 (2015); 42-50 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-4
Subject Terms: T1c, superficial bladder cancer, transurethral resection of bladder, transurethral resection of bladder en block, recurrence of bladder cancer, complications after transurethral resection, proper muscularis mucosa, T1a, T1b, поверхностный рак мочевого пузыря, трансуретральная резекция мочевого пузыря, трансуретральная резекция мочевого пузыря единым блоком, рецидив рака мочевого пузыря, осложнения после трансуретральной резекции, собственная мышечная пластинка слизистой оболочки, стадии T1a
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/473/489; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/473/111; Состояние онкологической помощи населению России в 2012 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2013. [Incidence of malignant neoplasms in Russia in 2012. Eds. by: А.D. Kaprin, V.V. Starinskiy, Moscow, 2013. (In Russ.)].; Kausch von Schmeling I. Diagnosis of and therapy for non-muscle-invasive bladder cancer – state of the art. Aktuelle Urol 2010;41(5):307–15.; Sylvester R.J., van der Meijden A.P., Oosterlinck W. Predicting recurrence and progression in individual patients with stage Та T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466–77.; Hu Z., Mudaliar K., Quek M.L. et al. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence. Ann Diagn Pathol 2014;18(2):49—52.; Bobiński J., Lipiński M. EORTC risk tables–a new diagnostic tool in urology. Pol Merkur Lekarski 2009;27: 524–8.; Zehnder P., Thalmann G.N. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer. Curr Opin Urol 2013;23(5):423–8.; Hermann G.G., Horn T., Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998;159(1):91–4.; Platz C.E., Cohen M.B., Jones M.P. et al. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996;9:1035–9.; Cheng L., Weaver A.L., Neumann R.M. et al. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999;86:1035–43.; Angulo J.C., Lopez J.I., Grignon D.J., Sanchezhapado M. Muscularis mucosa differentiates 2 populations with different prognosis in stage T1 bladder-cancer. Urology 1995;45:47–53.; Holmang S., Hedelin H., Anderstrom C. et al. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997;157:800–4.; Orsola A., Trias I., Raventos C.X. et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005;48(2):231–8.; Rouprêt M., Seisen T., Compérat E. et al. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladdercarcinoma: French national multicenter study with central pathology review. J Urol 2013;189(6):2069–76.; Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The world health organization/ international society of urological patology consensus classification of urotelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22(12): 1435–48.; KawadT., Ebihara K, Suzuki T. et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 1997;157(6):2225–6.; Naselli A., Introini C. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int 2012;109: 960–3.; Upadhyay R., Kapoor R., Srivastava A. et al. Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? Indian J Urol 2012;28(3):275–9.; Muto G., Collura D., Giacobbe A. et al. Thulium: yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology 2014; 83(4):851–5.; Lodde M., Lusuardi L., Palermo S. et al. En bloc transurethral resection of bladder tumors: use and limits. Urology 2003;62(6): 1089–91.; Мартов А.Г., Ергаков Д.В., Байков Н.А. и др. Трансуретральное удаление опухолей мочевого пузыря единым блоком. Онкоурология 2015;11(2):41–50. [Martov A.G., Ergakov D.V., Baukov N.A. et al. Transurethral en bloc resection of bladder tumors. Onkourologiya = Oncourologiya 2015;11(2):41–50. (In Russ.].; Rodríguez-Alonso A., Pita-Fernández S., González-Carreró J., Nogueira-March J.L. Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki-67. Actas Urol Esp 2003;27(2):132–41.; https://oncourology.abvpress.ru/oncur/article/view/473
-
8Academic Journal
Authors: УЛЬЯНИН М.Ю., БАСИАШВИЛИ Г.Т., ХАСАНОВ Р.Ш., ГАТАУЛЛИН И.Г., БУРМИСТРОВ М.В., ХАЙРУЛЛИНА Г.Р.
File Description: text/html
-
9Academic Journal
Authors: М. Yu. Ulyanin, G. Т. Basiashvili, R. Sh. Khasanov, М. V. Burmistrov, I. G. Gataullin, М. Ю. Ульянин, Г. Т. Басиашвили, Р. Ш. Хасанов, М. В. Бурмистров, И. Г. Гатауллин
Source: Siberian journal of oncology; № 5 (2015); 30-36 ; Сибирский онкологический журнал; № 5 (2015); 30-36 ; 2312-3168 ; 1814-4861 ; undefined
Subject Terms: поверхностный рак мочевого пузыря, трансуретральная резекция мочевого пузыря единым блоком, результаты лечения
File Description: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/146/148; Державец Л.А. Лабораторные показатели и выживаемость пациентов, страдающих раком мочевого пузыря // Сибирский онкологический журнал. 2013. № 4. С. 12–16.; Злокачественные новообразования в России в 2012 г. / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2015. 250 с.; Мартов А.Г., Ергаков Д.В., Байков Н.А., Поминальная В.М., Соломатов И.А. Трансуретральное удаление опухолей мочевого пузыря единым блоком // Онкоурология. 2015. Т. 1, № 1. С. 41–49.; Allard P., Bernard P., Fradet Y., Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index // Br. J. Urol. 1998. Vol. 81 (5). P. 692–698.; Domínguez G., Carballido J., Silva J., Silva J.M., García J.M., Menéndez J., Provencio M., España P., Bonilla F. p14ARF promoter hypermetylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients // Clin. Cancer Res. 2002. Vol. 8 (4). P. 980–985.; Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The world health organization/international society of urological patology consensus classification of urotelial (transitional cell) neoplasms of the urinary bladder // Am. J. Surg. Pathol. 1998. Vol. 22 (12). P. 1435–1448.; Herr H.W., Donat M.S. Quality control in transurethral resection of bladder tumors // BJU Int. 2008. Vol. 102 (9. Pt. B). P. 1242–1246. doi:10.1111/j.1464-410X.2008.07966.x.; Hu Z., Mudaliar K., Quek M.L., Paner G.P., Barkan G.A. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence // Ann. Diagn. Pathol. 2014. Vol. 18 (2). P. 49–52. doi:10.1016/j.anndiagpath.2013.11.002.; Kawada T., Ebihara K., Suzuki T., Imai K., Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode // J. Urol. 1997. Vol. 157 (6). P. 2225–2226.; Lodde M., Lusuardi L., Palermo S., Signorello D., Maier K., Hohenfellner R., Pycha A. En bloc transurethral resection of bladder tumors: use and limits // Urology. 2003. Vol. 62 (6). P. 1089–1091.; Millán-Rodríguez F., Chéchile-Toniolo G., Salvador-Bayarri J., Palou J., Algaba F., Vicente-Rodríguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence // J. Urol. 2000. Vol. 164 (3. Pt 1.) P. 680–684.; Muto G., Collura D., Giacobbe A., D’Urso L., Muto G.L., Demarchi A., Coverlizza S., Castelli E. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages // J. Urology. 2014. Vol. 83 (4). P. 851–855. doi:10.1016/j.urology.2013.12.022.; Naselli A., Introini C., Germinale F., Spina B., Puppo P. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm // BJU Int. 2012. Vol. 109 (6). P. 960–963. doi:10.1111/j.1464410X.2012.10982.x.; Saito S. Transurethral en bloc resection of bladder tumors // J. Urol. 2001. Vol. 166 (6). P. 2148–2150.; Upadhyay R., Kapoor R., Srivastava A., Krishnani N., Mandhani A. Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? // Indian J. Urol. 2012. Vol. 28 (3). P. 275–279. doi:10.4103/0970-1591.102700.; https://www.siboncoj.ru/jour/article/view/146; undefined
Availability: https://www.siboncoj.ru/jour/article/view/146
-
10Academic Journal
File Description: text/html
-
11Academic Journal
Authors: A. G. Martov, D. V. Ergakov, N. A. Baykov, V. M. Pominalnaya, I. A. Solomatnikov, А. Г. Мартов, Д. В. Ергаков, Н. А. Байков, В. М. Поминальная, И. А. Соломатников
Source: Cancer Urology; Том 11, № 1 (2015); 41-49 ; Онкоурология; Том 11, № 1 (2015); 41-49 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-1
Subject Terms: in situ bladder cancer, noninvasive bladder cancer, transurethral resection of the bladder, holmium resection of the bladder, laser resection of the bladder, en bloc endoscopic resection of the bladder, en bloc techniques, recurrent bladde, неинвазивный рак мочевого пузыря, трансуретральная резекция мочевого пузыря, гольмиевая резекция мочевого пузыря, лазерная резекция мочевого пузыря, эндоскопическая резекция мочевого пузыря единым блоком, техника единого блока
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/416/426; Grasso M. Bladder cancer: a major public health issue. Eur Urol Suppl 2008;7:510–15.; Saito S. Transurethral en bloc resection of bladder tumors. J Urol 2001;166:2148–50.; Мартов А.Г., Ергаков Д.В., Андронов А.С. Рецидивирование мышечно-неинвазивного рака мочевого пузыря: возможные эндоскопические пути решения проблемы. Онкоурология 2010;1:6–14. [Martov A.G., Ergakov D.V., Andronov A.S. Recurrent nonmuscle invasive bladder cancer: possible endoscopic modes to solve the problem. Onkourologiya = Oncourology 2010;1:6–14 (In Russ.)].; Мартов А.Г., Андронов А.С., Ергаков Д.В., Дутов С.В. NBI и SPIES диагностика папиллярных опухолей верхних мочевых путей. 1 Интернациональный и 4 Российский конгресс по эндоурологии и новым технологиям. Батуми, 2014. С. 104–106 [Martov A.G., Andronov A.S., Ergakov D.V., Dutov S.V. NBI and SPIES diagnosis of papillary tumors of the upper urinary tract. I International and IV Russian Congress on endourology and new technologies. Batumi, 2014. P.104–106 (In Russ.)].; Brausi M., Collette L., Kurth K. et al. Variability in the recurrence rate at first followup cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 2002;41:523–31.; Sylvester R.J., Oosterlinck W., van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta-T1 bladder cancer: A metaanalysis of published results of randomized clinical trials. J Urol 2004;171: 2186–90.; Xishuang S., Deyong Y, Xiangyu C. et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 2010;24(1):69–73.; Muto G., Collura D., Giacobbe A. et al. Thulium: yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology 2014;83(4):851–5.; https://oncourology.abvpress.ru/oncur/article/view/416
-
12Academic Journal
Authors: УЛЬЯНИН МИХАИЛ ЮРЬЕВИЧ, БАСИАШВИЛИ ГЕОРГИЙ ТАРИЕЛОВИЧ, ХАСАНОВ РУСТЕМ ШАМИЛЬЕВИЧ, БУРМИСТРОВ МИХАИЛ ВЛАДИМИРОВИЧ, ГАТАУЛЛИН ИЛЬГИЗ ГАБДУЛЛОВИЧ
File Description: text/html
-
13Academic Journal
Source: Онкоурология.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, 3. Good health, РАК МОЧЕВОГО ПУЗЫРЯ,ПОВЕРХНОСТНЫЙ РАК МОЧЕВОГО ПУЗЫРЯ,ТРАНСУРЕТРАЛЬНАЯ РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ,ТРАНСУРЕТРАЛЬНАЯ РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ ЕДИНЫМ БЛОКОМ,РЕЦИДИВ РАКА МОЧЕВОГО ПУЗЫРЯ,ОСЛОЖНЕНИЯ ПОСЛЕ ТРАНСУРЕТРАЛЬНОЙ РЕЗЕКЦИИ,СОБСТВЕННАЯ МЫШЕЧНАЯ ПЛАСТИНКА СЛИЗИСТОЙ ОБОЛОЧКИ,СТАДИИ T1A T1B T1C
File Description: text/html
-
14Academic Journal
Source: Онкоурология.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, EXTRAADRENAL PHEOCHROMOCYTOMAS,PARAGANGLIOMA OF THE URINARY BLADDER,DIAGNOSIS,SCINTIGRAPHY WITH MIBG,TRANSURETHRAL RESECTION OF THE BLADDER,RADICAL CYSTECTOMY,ВНЕНАДПОЧЕЧНИКОВЫЕ ФЕОХРОМОЦИТОМЫ,ПАРАГАНГЛИОМА МОЧЕВОГО ПУЗЫРЯ,ДИАГНОСТИКА,СЦИНТИГРАФИЯ C MIBG,ТРАНСУРЕТРАЛЬНАЯ РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ,РАДИКАЛЬНАЯ ЦИСТЭКТОМИЯ, 3. Good health
File Description: text/html
-
15Academic Journal
Authors: O. A. Khalmurzaev, V. B. Matveev, S. B. Peterson, V. A. Romanov, A. D. Panakhov, A. V. Khailenko, О. А. Халмурзаев, В. Б. Матвеев, С. Б. Петерсон, В. А. Романов, А. Д. Панахов, А. В. Хайленко
Source: Cancer Urology; Том 8, № 2 (2012); 66-71 ; Онкоурология; Том 8, № 2 (2012); 66-71 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2012-8-2
Subject Terms: рестадирование, transurethral resection of the bladder, second look, incidence of recurrences, restaging, трансуретральная резекция мочевого пузыря, частота встречаемости рецидивов
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/336/353; Матвеев Б.П. Клиническая онкоурология. М., 2011.; Sylvester R.J., van der Meijden A.P., Oosterlinck W. et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466−77.; Нerr H., Dalbagni G. Is «second −look» (re-staging) transurethral resection of bladder tumors a new standard of care? Arab J Urol 2011;9:7−10.; Herr H.W. A restaging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2006; 97:1194−8.; Soloway M., Safer M., Vaidya A. Contemporary management of stage Tl transitional cell carcinoma of the bladder. J Urol (Baltimore) 2002;167:1573−83.; Babjuk M., Oosterlinck W., Sylvester R. et al. EAU guidelines on nonmuscle- invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303−14.; Schips L., Augustin H., Zigeuner R.E. et al. Is repeat transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002;59:220−3.; Grimm M.O. Steinhoff Ch., Simon X. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003;170 (2 Pt 1): 433−7.; Brauers A., Buettner R., Jakse G. Second resection and prognosis in primary high risk superficial bladder cancer. J Urol 2001; 165:808−10.; Herr H.W. A restaging transurethral resection of high risk superficial bladder cancer improves the initial response to BCG therapy. J Urol 2005;174:2134−7.; Dalbagni G. Bladder cancer: Restaging TUR reduces recurrence and progression risk. Nat Rev Urol 2010;7(12):649−50.; https://oncourology.abvpress.ru/oncur/article/view/336
-
16Academic Journal
Authors: O. A. Khalmurzayev, V. B. Matveev, R. M. Figurin, V. A. Romanov, A. D. Panakhov, K. O. Khafizov, О. А. Халмурзаев, В. Б. Матвеев, К. М. Фигурин, В. А. Романов, А. Д. Панахов, К. О. Хафизов
Source: Cancer Urology; Том 8, № 4 (2012); 33-39 ; Онкоурология; Том 8, № 4 (2012); 33-39 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2012-8-4
Subject Terms: рестадирование, transurethral resection of the bladder, second look, incidence of recurrences, restaging, трансуретральная резекция мочевого пузыря, частота встречаемости рецидивов
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/353/370; Злокачественные новообразования в России в 2010 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М., 2010.; Матвеев Б.П. Клиническая онкоурология. М., 2011.; Dominguez G., Carballido J., Silva J. et al. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients. Clin Cancer Res 2002;8:980−5.; Русаков И.Г., Быстров А.А. Хирургическое лечение, химио- и иммунотерапии больных поверхностным раком мочевого пузыря. Практ онкол 2003;1:107−16.; Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999;162:74−6.; Klan R., Loy V., Huland H. Residual tumor discovered in routine second TUR in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 1991;146:316.; Herr H., Dalbagni G. Is second-look (re-staging) Transurethral resection of bladder tumors a new standard of care? Arab J Urol 2011;9:7−10.; Ali M.H., Ismail I.Y., Eltobgy A., Gobeish A. Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cance r. J Endourol 2010;24(12):2047−50.; Dalbagni G., Vora K., Kaag M. et al. Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1. Blad Cancer 2009;56:903−10.; Divrik R.T., Ali F.S., et al. Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial. Eur Urol 2010;5(8):185−90.; Han K.S., Kyung Seok Han, Jae Young Joung et al. Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer. J Endourol 2008;22(12):2699−704.; Schips L., Augustin H., Zigeuner R.E. et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002;59(2):220−3. http://www.ncbi.nlm.nih.gov/pubmed/11834389; Schwaibold H.E., Sivalingam S., May F. et al. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006; 97:1199−201.; Cheng L., Montironi R., Davidson D., Lopez-Beltran A. Staging and reporting of urotelial carcinoma of the urinary bladder. Mod Pathol 2009;22:70−95.; Zlotta A.R., van Vooren J.P., Huygen K. et al. What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary? Eur Urol 2000; 37(4):470−7. http://www.ncbi.nlm.nih.gov/pubmed/10765079; Herr H.W. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 2005;174:2134−7.; Stern M. Resections of obstructions at the vesical orifice. J Am Med Asso 1926; 87:1726−9.; Herr H.W., Donat S.M., Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? Department of Urology, Memorial Sloan-Kettering Cancer Center, New York. NY, 2007.; Grimm M.O., Steinhoff Ch., Simon X. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003;170(2 Pt 1):433−7.; Kulkarni G.S., Oliver W. Hakenberg, Juergen E. Gschwend et al. An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer Accepted 26 August 2009. Eur Urol 2010;57(1): 60−70.; https://oncourology.abvpress.ru/oncur/article/view/353
-
17Academic Journal
Authors: Халмурзаев, О., Матвеев, В., Петерсон, С., Романов, В., Панахов, А., Хайленко, А.
Subject Terms: НЕМЫШЕЧНО-ИНВАЗИВНЫЙ РАК МОЧЕВОГО ПУЗЫРЯ, ТРАНСУРЕТРАЛЬНАЯ РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ, ЧАСТОТА ВСТРЕЧАЕМОСТИ РЕЦИДИВОВ, РЕСТАДИРОВАНИЕ
File Description: text/html
-
18Academic Journal
Authors: Borzunov, I. V., Борзунов, И. В.
Subject Terms: CYSTITIS, TRANSURETHRAL RESECTION OF BLADDER, SURFACE BLADDER CANCER, ЦИСТИТ, ТРАНСУРЕТРАЛЬНАЯ РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ, ПОВЕРХНОСТНЫЙ РАК МОЧЕВОГО ПУЗЫРЯ
File Description: application/pdf
Relation: Уральский медицинский журнал. 2011. T. 79, № 1.; http://elib.usma.ru/handle/usma/15962
Availability: http://elib.usma.ru/handle/usma/15962
-
19Academic Journal
Authors: A. V. Semenov, A. A. Kosulina, А. В. Семенов, А. А. Косулина
Source: Cancer Urology; Том 7, № 4 (2011); 37-41 ; Онкоурология; Том 7, № 4 (2011); 37-41 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2011-7-4
Subject Terms: риск рецидивирования, repeat transurethral resection of the bladder, relapse-free survival, restaging, risk for recurrence, повторная трансуретральная резекция мочевого пузыря, безрецидивная выживаемость, рестадирование
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/218/235; Oosterlinck W., Lobel B., Jakse G. et al. European Association of Urology (EAU) Working Group on Oncological Urology. Guidelines on bladder cancer. Eur Urol 2002;41(2):105−12.; Sylvester R.J., van der Meijden A.P., Oosterlinck W. et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49(3):466−77.; Brausi M., Collette L., Kurth K. et al. EORTC Genito-Urinary Tract Cancer Collaborative Group. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002;41(5):523−31.; Jahnson S., Wiklund F., Duchek M. et al. Results of second-look resection after primary resection of T1 tumour of the urinary bladder. Scand J Urol Nephrol 2005;39(3):206−10.; Witjes J.A., Douglass J. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Nat Clin Pract Urol 2007;4:542–9.; Divrik T., Yildirim U., Eroglu A.S. et al. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 2006; 175:1258–61.; Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999; 162:74–6.; Brauers A., Buettner R., Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 2001;165(3):808–10.; Schips L., Augustin H., Zigeuner R.E. et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002;59(2):220–3.; Grimm M.-O., Steinhoff Ch., Simon X. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170(2 Pt 1):433–7.; Herr H.W., Donat M. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2006; 97:1194−8.; https://oncourology.abvpress.ru/oncur/article/view/218
-
20Academic Journal
Authors: Семенов, А., Косулина, А.
Subject Terms: НЕМЫШЕЧНО-ИНВАЗИВНЫЙ РАК МОЧЕВОГО ПУЗЫРЯ, ПОВТОРНАЯ ТРАНСУРЕТРАЛЬНАЯ РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ, БЕЗРЕЦИДИВНАЯ ВЫЖИВАЕМОСТЬ, РЕСТАДИРОВАНИЕ, РИСК РЕЦИДИВИРОВАНИЯ
File Description: text/html
